Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 549,000 | 780,000 | 432,000 | N/A | N/A |
| Marketable Securities | 9,000 | 25,000 | N/A | N/A | N/A |
| Receivables | 214,000 | 341,000 | 427,000 | N/A | N/A |
| Inventories | 141,000 | 184,000 | 199,000 | N/A | N/A |
| Income taxes - deferred | 6,000 | 6,000 | 45,000 | N/A | N/A |
| Other current assets | 1,119,000 | 1,467,000 | 560,000 | 0 | 0 |
| TOTAL | $2,038,000 | $2,803,000 | $1,663,000 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 7,117,000 | 8,934,000 | 9,017,000 | N/A | N/A |
| Investments And Advances | 0 | 15,000 | 79,000 | 0 | 0 |
| Intangibles | 380,000 | 870,000 | 935,000 | 0 | 0 |
| Other Non-Current Assets | 1,418,000 | 1,591,000 | 1,527,000 | 0 | 0 |
| TOTAL | $8,915,000 | $11,410,000 | $11,558,000 | $N/A | $0 |
| Total Assets | $10,953,000 | $14,213,000 | $13,221,000 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 807,000 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 181,000 | 303,000 | 292,000 | 0 | 0 |
| Accrued Expenses | 163,000 | 216,000 | 257,000 | N/A | N/A |
| TOTAL | $1,847,000 | $1,702,000 | $999,000 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,775,000 | 6,072,000 | 5,939,000 | N/A | N/A |
| Other Non-Current Liabilities | 587,000 | 791,000 | 520,000 | 0 | 0 |
| TOTAL | $6,127,000 | $8,026,000 | $7,716,000 | $N/A | $N/A |
| Total Liabilities | $7,974,000 | $9,728,000 | $8,715,000 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 1,000 | 8,000 | 8,000 | N/A | N/A |
| Retained earnings | -2,937,000 | -1,690,000 | -1,864,000 | N/A | N/A |
| Other shareholders' equity | -75,000 | -247,000 | -30,000 | 0 | 0 |
| TOTAL | $2,979,000 | $4,485,000 | $4,506,000 | $N/A | $N/A |
| Total Liabilities And Equity | $10,953,000 | $14,213,000 | $13,221,000 | $0 | $0 |